Related Experiment Video

Updated: Jul 4, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

[Crosstalk between cholesterol homeostasis and drug metabolism]

Krisztina Kohalmy1, Damjana Rozman, Jean-Marc Pascussi

  • 1Magyar Tudományos Akadémia, Kémiai Kutatóközpont Farmakobiokémiai Osztály Budapest.

Orvosi Hetilap
|June 27, 2008
PubMed

Insights

High cholesterol contributes to cardiovascular disease mortality. Therapies like statins and ezetimibe lower cholesterol by reducing synthesis or uptake, impacting drug metabolism via nuclear receptors.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cardiovascular Medicine

Context:

  • Cardiovascular diseases (CVDs) are a leading cause of mortality globally.
  • Elevated blood cholesterol and atherosclerosis are key drivers of CVD progression.
  • Therapeutic interventions aim to reduce serum cholesterol levels to mitigate adverse effects and improve outcomes.

Purpose:

  • To explore the role of cholesterol-lowering therapies in regulating gene expression.
  • To investigate the interplay between cholesterol homeostasis and drug metabolism.
  • To highlight the significance of nuclear receptors in mediating these interactions.

Summary:

  • Statins reduce cholesterol biosynthesis, while ezetimibe inhibits dietary cholesterol absorption.
  • Combined statin and cholesterol uptake inhibitor therapy offers an efficient treatment strategy.
  • Cholesterol-modulating agents influence the expression of cholesterogenic and drug-metabolizing enzymes, including cytochromes P450.
  • This regulation is mediated by nuclear receptors responding to various ligands.

Impact:

  • Enhanced understanding of the cholesterol-drug metabolism crosstalk is crucial for effective therapeutic strategies.
  • This knowledge aids in the development of novel drugs with improved efficacy and safety profiles.
  • Optimizing combination therapies can lead to better management of cardiovascular diseases and related conditions.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Related Concept Videos

Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...